I’m an internationally recognized consultant and author with over 25 years of experience in the field of strategy development and execution, business model design, and market analysis.
Copyright 2011 AP. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
So, what are PBMs and how did we get here? Essentially, PBMs administer prescription drug insurance benefits. They are one component of the complex web of players that impact the healthcare landscape—a topic that I have discussed in otherbefore. The history of PBMs is entwined with the history of pharmaceutical companies, pharmacies, and the broader industry as a whole.
However, PBMs’ recent move toward consolidation—driven by an interest in driving growth and minimizing competition—has caused them to stray from their original purpose. Over the decades, the PBM industry has undergone significant consolidation. Today, three PBMs—CVS Caremark, Express Scripts, and OptumRx—dominate the market, handlingof all prescription drug claims in the United States.
To understand the case, it’s important to know how PBMs profit through rebates negotiated with drug manufacturers. First, they can profit by retaining a portion of the rebate and passing only some to the insurer. Second, PBMs make money by spread pricing, a process in which PBMs charge insurers more for a drug than they pay pharmacies and pocket the difference.
Lastly, the investigation raises concerns about the transparency of PBM operations. The current way by which PBMs make their money is opaque and described by insiders as ‘complex.’ The complexity is in large part by design which makes it difficult for payers and policymakers to understand the true costs and benefits of PBM services, and nearly impossible for patients to know what they will be charged for a drug.
PBM Express Scripts Optumrx CVS Caremark
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Another Scrapped Hospital Deal Pins 'Fate' on FTCTwo North Carolina hospitals face an uncertain future after a proposed sale fell through June 18.
Les mer »
FTC says TikTok may be violating child privacy law, refers matter to DOJOne of the most popular social media apps is in more hot water with federal regulators.
Les mer »
FTC and State AGs Sue to Block Kroger-Albertsons 'Mega Merger'Jake Johnson is a senior editor and staff writer for Common Dreams.
Les mer »
FTC opens investigation into Teva, escalating patent fight with pharmaDemocrats have accused drug companies of “junk patent listings,” arguing that the industry is blocking generic competition and inflating patients’ costs.
Les mer »
FTC unanimously moves to block Tempur Sealy's purchase of Mattress FirmThe Federal Trade Commission has unanimously voted to bring a lawsuit against mattress maker Tempur Sealy to block its $4 billion acquisition of Mattress Firm, saying the deal would allow the world’s largest mattress supplier to suppress competition that would result in higher prices for shoppers.
Les mer »
FTC votes to block merger of Tempur Sealy and Mattress FirmThe $4 billion merger, announced in May 2023, would combine the mattress manufacturer, which owns brands Stearns & Foster and Tempur-Pedic, with the nation’s largest mattress retailer.
Les mer »